Search results
3 Stocks to Snag While the Analysts Snooze
InvestorPlace· 8 hours agoFor many retail investors, it comes down to either buying index funds, mutual funds or exchange-traded funds. On the contrary, sometimes the most...
5 mind-bending buildings from Las Vegas to Dubai that never broke ground — and what stands in their...
Business Insider via Yahoo News· 1 day agoThe global financial crisis in 2009 thwarted plans for Hadid's Dubai Opera House complex. Hadid died...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 6 days agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
Results: 2024 Anchorage Mayor's Marathon, Half Marathon, Relay and Solstice Classic
Anchorage Daily News· 4 hours agoIsabelle Zink, Anne Zink and Amber Rinella, all from Palmer, AK, come out of the tunnel under...
The Star Trek Episode That Deeply Impacted Rod Roddenberry - SlashFilm
/Film· 1 day agoTrek" episode "The Devil in the Dark" (March 9, 1967), Captain Kirk (William Shatner) and Spock...
Active management vaults ETFs into asset-backed securities market
Pensions & Investments· 6 days agoCollectively, these securitized credit ETFs managed $13.5 billion, led by the $10.2 billion Janus Henderson AAA CLO ETF (JAAA), having taken in $4.8 billion since December ...
Questor: This gearbox manufacturer is set to boom – despite the EV revolution
The Telegraph via Yahoo Finance· 23 hours agoThe energy transition has created uncertainty for investors. That’s thrown up both risks and...
5 Growth Stocks to Buy for an Imposing Election Year Rally
Zacks· 13 hours agoDow Jones Market Data stated that the S&P 500 is on pace to register its best performance in the...
Higher-for-Longer Rates Are an Opportunity for Active Investors
Barrons.com· 6 days agoFEATURE About the authors: Ali Dibadj is chief executive officer of Janus Henderson Investors. Matt...
Day One Biopharmaceuticals (NASDAQ:DAWN) Receives “Buy” Rating from HC Wainwright
ETF DAILY NEWS· 4 days agoDay One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research report issued on Thursday, Benzinga reports ...
